Riskpilot← Back to searchSign inGet full accessOculorum AB
ABActiveOrg 5590623244Slätpricksvägen 1 BComputer programming activities · NACE 6210Est. 20161 employees
Revenue 2024
SEK 1,4M
-6% vs 2023
EBITDA margin
69.1%
+73% vs 2023
Equity ratio
54.3%
Financial strength
Net profit 2024
SEK 592K
+71% vs 2023
| Revenue | SEK 1,4M | -6% |
| EBITDA | SEK 968K | +73% |
| Net profit | SEK 592K | +71% |
| Total assets | SEK 2,5M | +25% |
| Equity | SEK 1,4M | +30% |
| Employees | 1 | — |
Legal name
Oculorum AB
Org number
5590623244
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
11 maj 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultativ verksamhet i IT branschen, forskning och marknadsföring av medicinska produkter, vidare skall bolaget förvärva och förvalta fast och lös egendom och värdepapper samt bedriva därmed förenliga verksamheter.
Address
Slätpricksvägen 1 B
Email
axel@oculorum.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 875 | 1 889 | 1 549 | 1 493 | 1 401 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 930 | 967 | 442 | 560 | 968 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 930 | 967 | 442 | 560 | 968 |
| Net financials | — | −10 | 3 | 34 | 43 |
| Profit before tax | 695 | 715 | 332 | 441 | 752 |
| Tax | −150 | −149 | −70 | −95 | −160 |
| Net profit | 545 | 566 | 262 | 346 | 592 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 294 | 1 843 | 1 999 | 2 009 | 2 517 |
| Equity | 818 | 1 125 | 1 087 | 1 053 | 1 366 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 105 | 105 | 185 | 76 | 12 |
| Total debt | 105 | 105 | 185 | 76 | 12 |
EBITDA margin
69.1%
This company
15.8%
Market median
+337% vs market
20202024
Equity ratio
54.3%
This company
38.2%
Market median
+42% vs market
20202024
Return on equity
43.3%
This company
18.4%
Market median
+135% vs market
20202024
Net profit margin
42.3%
This company
8.1%
Market median
+422% vs market
20202024
Asset turnover
0.56×
This company
1.12×
Market median
-50% vs market
20202024
Debt / equity
0.84×
This company
0.62×
Market median
+35% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Oculorum AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Maria Zander | Deputy Board Member | 0 companies |
| Peer Axel Zander | Board of Directors | 0 companies |